The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...

The powerful gene-editing technique CRISPR–Cas9 might offer a way to make safer, more effective cancer-fighting immune cells ...

Tools like CRISPR-Cas9 are creating new opportunities for innovation in St. Louis, as well as risks around IP protection and regulation.

Adoptive cell therapy (ACT) has emerged as a transformative approach in cancer immunotherapy, with remarkable clinical success in hematological ...

Over the past 25 years, a Canadian medical journal has been publishing fictional clinical case reports but framing them as ...

Unlike genetics, which often focuses on individual genes and their roles in inheritance, genomics looks at how all genes interact within networks and across environments.

CHICAGO, IL, UNITED STATES, March 4, 2026 /EINPresswire.com/ -- At Chicago Waldorf High School (CWHS), senior year is ...

The U.S. Food and Drug Administration approved the first cell-based gene therapies for sickle cell disease, including the ...

The cost of sequencing a human genome has fallen from $100 million in 2001 to around $1,000 today—dropping even faster than Moore’s Law predicted. At the center of this revolution is CRISPR, a ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

I was born in Washington, DC, in 1964, the oldest of three sisters, but the place that truly formed me as a scientist was Hilo, on the Big Island of Hawaii. Growing up there, far from the mainland ...

The framework, first introduced by FDA Commissioner Marty Makary and Center for Biologics Evaluation and Research head Vinay Prasad in November, was criticized for lacking detailed guidance. Agency ...